Cyclobenzaprine Usage and Precautions

Discontinuation and Tapering

When discontinuing cyclobenzaprine after long-term use, a gradual taper over 2-3 weeks should be implemented to prevent withdrawal symptoms, including malaise, nausea, and headache, as recommended by the American College of Physicians and supported by evidence from Mayo Clinic Proceedings 1, 2

Cyclobenzaprine is a centrally acting skeletal muscle relaxant, structurally related to tricyclic antidepressants, and is primarily indicated for relief of muscle spasm associated with acute, painful musculoskeletal conditions, according to the Mayo Clinic Proceedings and Praxis Medical Insights 1, 2
The European League Against Rheumatism recommends cyclobenzaprine for fibromyalgia management, though with only a weak recommendation (75% expert agreement) and moderate evidence quality, as reported in the Annals of the Rheumatic Diseases 3

The American Geriatrics Society Beers Criteria identifies muscle relaxants, including cyclobenzaprine, as potentially inappropriate medications for older adults due to anticholinergic effects and sedation, as stated in the Journal of the American Geriatrics Society 4
The Mayo Clinic advises holding cyclobenzaprine on the day of surgery due to potential interactions with anesthetics and sedatives 2

Patients should be informed about anticholinergic side effects, such as dry mouth, constipation, and urinary retention, and advised to monitor for these effects, as recommended by Praxis Medical Insights and supported by evidence from Mayo Clinic Proceedings 1, 2
Patients should be instructed not to abruptly discontinue cyclobenzaprine after prolonged use, to avoid withdrawal symptoms, as recommended by the American College of Physicians and supported by evidence from Mayo Clinic Proceedings and Praxis Medical Insights 1, 2